Shota Kaburaki

4PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 22, 2026
Aberrant expression of the PREX2-MAGI2 axis modulates myofibroblast differentiation in pulmonary fibrosis.

|Jun 21, 2026
Mepolizumab initiation by day 30 and glucocorticoid exposure in newly diagnosed EGPA: a single-center 30-day landmark cohort study.

|Apr 18, 2025
Early Intervention with Mepolizumab, Corticosteroids, and Intravenous Immunoglobulin for Dupilumab-Triggered Eosinophilic Granulomatosis with Polyangiitis: A Case Report.

Shota Kaburaki, Toru Tanaka, Koichiro Kamio

|Nov 26, 2024
The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report With Transbronchial Lung Cryobiopsy.

Shota Kaburaki, Toru Tanaka, Akari Murata

Pageof 1

Frequent Collaborators

2 joint publications

Yosuke Tanaka

1 joint publications

Koichiro Kamio

1 joint publications

Yasuhiro Terasaki

1 joint publications

Keisuke Yoshida